Skip to main content
OpenTrials
Completed

NCT Number: NCT00229463

Study of Genetic Differences in People With Depression

The purpose of this study is to identify genes involved in depression. Specifically, the investigators will analyze some genes that may be related to whether or not a person responds to antidepressant medication. This project is part of basic scientific research to increase understanding of the role of genetic influences in psychological and mental processes involved in the response to treatment for depression.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

UCLA Semel Institute for Neuroscience and Human Behavior

Los Angeles, California, 90024, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • History of Unipolar Major Depression
  • Control subjects must be healthy normal adults

Exclusion criteria

  • Subjects with mood symptoms that are not severe enough to qualify for MDD
  • Subjects with any active medical illness that may be related to ongoing mood disorder
  • Normal subjects must be free from: a psychiatric diagnosis, substance abuse, a history of seizure disorder, and any serious medical illness

Sponsors and collaborators

Lead sponsor

University of California, Los Angeles

Other

Registry information

Acronym: Genetics

Important dates

Study start
2002
Primary completion
2011
Study completion
2011
First posted
Sep 29, 2005
Registry last updated
Nov 18, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.